Acute gastrointestinal inflammation is a common gastrointestinal disease often caused by a number of factors, while antibacterial treatment plays a key role in some cases. Understanding the relationship between acute gastrointestinal inflammation and antibacteria is important for the proper response to the disease and for the promotion of rehabilitation.
I. Causes of acute gastrointestinal disease and bacterial factors. Among these, bacterial infection from the infection factor is one of the more common causes. The most common pathogenic bacteria are salmonella, coli, Shigaella, Bacillus, etc. These bacteria can enter the human gastrointestinal tract in a number of ways, such as eating bacterial contaminated foods (uncooked meat, seafood, spoiled fruit, vegetables, contaminated drinking water, etc.) or being transported into the body through the mouth after exposure to contaminated objects. Once in the gastrointestinal tract, bacteria breed in large quantities in the appropriate environment and release toxins, disrupt the normal structure and functioning of the intestinal mucous membranes, and cause inflammatory reactions, leading to a series of symptoms such as abdominal pain, diarrhoea, nausea, vomiting and fever. For example, salmonella infections can cause severe diarrhoea, with a high incidence of feces of water or yellow-green rareness, often accompanied by heat, abdominal pain and pain in the umbilical week or lower abdominal; certain pathogenic strains of colicoccus, such as intestinal haemorrhage coliform O157:H7, can produce irritating toxins, which not only cause haemorrhage from intestinal mucous membranes, but can also cause serious complications such as a combination of soluble urine poisoning, threatening life and health.
II. Adaptation certificates for antibacterial treatment. Not all acute gastrointestinal disease requires antibacterial treatment. In general, acute gastrointestinal inflammation, most of which is caused by viral infections (e.g., rotavirus, noxious viruses, etc.), usually does not require the use of antibacterial drugs because of the self-restrictive nature of the infection, and is mainly treated with symptoms such as rehydration and electrolytics, abdominal diarrhoea relief, etc., most of which can be recovered by the patient within days to one week. However, when acute gastrointestinal inflammation is clearly caused by bacterial infections and accompanied by: 1. Symptoms are severe: frequent and severe vomiting, high levels of diarrhoea leading to dehydration or electrolyte disorders are difficult to correct through simple rehydration, and the high fever persists. 2. Special population groups: children, the elderly, pregnant women and those with low immune functions (e.g., AIDS patients, chronic use of immunosuppressants or those receiving chemotherapy, etc.) who are more vulnerable to serious complications following bacterial infections due to their weak immune function, often requiring timely antibacterial treatment once diagnosed as bacterial infectious acute gastrointestinalitis. 3. Suspected of intrusive bacterial infections: symptoms such as mucous sepsis, dysentery, suggesting the possible presence of invasive bacterial infections such as Shigaella, at a time when antibacterial drugs are needed to control the infection and prevent further deterioration.
1. quinone types: e.g., Nofluorinated salsa, cyclopropsa, etc., which have a better antibacterial activity in the intestinal grenacella common to the intestinal tract, hinders bacterial DNA revolving enzymes from replicating for microbicide purposes. The average adult use is 0.3 – 0.4 g per NFS, 2 – 3 times per day; and 0.25 – 0.5 g per cyclopropsa, 2 times per day, usually 3 – 5 days. It should be noted, however, that quinone-type drugs are banned for children and adolescents under the age of 18, as they may affect bone development. 2. Hairbacteria: For some patients who are allergic or intolerant to quinone-type drugs, the option is to use a drug such as a headbactone. The head scrawl is resistant to various intestinal bacteria and it kills bacteria by inhibiting the synthesis of bacterial cell walls. Adults typically use 0.1 – 0.2g per day, 2 times per day, and children use about 3 – 7 days of treatment based on weight. 3. Archicin: Achcin is a more effective drug in certain special cases, such as suspected Bacillus. Archicin inhibits the synthesis of bacterial proteins and has a strong antibacterial activity for the fungus. The first day of an adult is taken 0.5g, followed by 0.25g per day for 2 – 5 days; the child ‘ s usage is adjusted to weight, usually 10 mg/kg per day for 3 days. The use of antibacterial drugs for the treatment of acute gastrointestinal inflammation should follow the advice of the doctor and be used at the correct dose, treatment and method of administration, avoiding the self-abuse of antibacterial drugs, leading to adverse consequences such as increased bacterial resistance and intestinal discomfort.
1. Timely medical diagnosis: Do not use antibacterial drugs blindly after acute gastrointestinal symptoms, and should be examined in a timely manner, including blood, urinary and culture, in order to identify the cause of the disease, determine whether antibacterial treatment is needed and select appropriate antibacterial drugs. 2. Observed adverse effects: Antibacterial drugs may cause a number of adverse effects, such as gastrointestinal disorders, dizziness, rashes, etc., as a result of quinone-type drugs; precipitine-likes may cause allergic reactions, diarrhoea, etc.; and acicin may cause gastrointestinal reactions such as nausea, vomiting, abdominal pain, etc. In the course of the medication, the patient should closely observe his or her own response and inform the doctor if he or she is unwell. 3. Hydraulic and electrolyte supplementation: anti-bacterial treatment cannot be ignored while correcting dehydration and electrolyte disorders in patients. Patients should be given appropriate drinking water from desalination water, oral rehydration salts or intravenous rehydration to maintain their internal water, electrolyte balance and promote physical recovery. 4. Dietary adjustment: During acute gastrointestinal inflammation, the diet principles of blight and digestive should be followed to avoid the consumption of spicy, greasy, irritating and cold foods, so as not to increase the gastrointestinal burden and affect the recovery of the condition. A gradual transition to a normal diet can begin with a permutation of food.
Antibacterial treatment for acute gastrointestinal disease requires careful treatment. Proper diagnosis of the condition, reasonable choice of antibacterial drugs, and close attention to the conditions in the treatment process are key to the effective treatment of acute gastrointestinalitis, the reduction of complications and the promotion of the rehabilitation of patients. At the same time, improved dietary hygiene management and good personal hygiene practices help to prevent the occurrence of acute gastrointestinal inflammation and to safeguard gastrointestinal health.
